Chemistry and pharma The potential for quantum computing in biological research Quantum computing is opening up new possibilities to advance bioscience research by accelerating drug discovery and helping to develop treatments for cancer, writes Eugenia Bahit Latest Content Metabolism prediction added in chemistry software update Pharma partnership showcases instant, secure transfer of analytical data In silico discovery and overcoming bias with AI New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Understanding compound selectivity with data-driven drug design Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Reducing Risk & Improving Synthesis Outcomes with SYNTHIA Retrosynthesis Software Addressing the many intrinsic and external challenges to chemical synthesis has led to a highly complex system of regulations that invo Enabling Remote Operations Many routine operations and maintenance tasks can be performed remotely. Webcasts A Cautionary Tale for AI in Small Molecule Drug Discovery More content How design of experiments lowers costs in R&D Partnership aims to bring pharmaceutical products to market quicker Collaboration aims to advance the discovery of novel cancer drugs Collaboration aims to Integrate AI drug discovery Iktos raises € 15.5m to expand its AI-based drug discovery technology AI shapes the future of precision medcine FDA asks for comment on AI manufacturing What you Need to Understand About the State of Analytical Data Management Today ACD/Labs releases v2022 software update A Cautionary Tale for AI in Small Molecule Drug Discovery Optibrium expands operations in North America Understanding compound selectivity with data-driven drug design Pagination Previous page ‹ Previous Page 2 Next page Next ›
